Clinical rationale and preclinical evidence for chimeric antigen receptor (CAR) T cell therapy clinical trial in KRAS-mutant lung cancer Meeting Abstract

  

Authors:	Minehart, J.; Eguchi, T.; Morello, A.; Adusumilli, P.
Abstract Title:	Clinical rationale and preclinical evidence for chimeric antigen receptor (CAR) T cell therapy clinical trial in KRAS-mutant lung cancer
Meeting Title:	20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC)
Keywords:	immunotherapy; non-small cell lung cancer; kras mutation
Journal Title:	Journal of Thoracic Oncology
Volume:	14
Issue:	10 Suppl.
Meeting Dates:	2019 Sept 7-10
Meeting Location:	Barcelona, Spain
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2019-10-01
Start Page:	S244
Language:	English
ACCESSION:	WOS:000492162201170
DOI:	10.1016/j.jtho.2019.08.485
PROVIDER:	wos
Notes:	Meeting Abstract: OA14.03 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/157470